Roche Gets FDA Clearance for cobas eplex RP3 Respiratory Test
Roche obtained FDA clearance for its cobas eplex RP3 respiratory test.
Related stories
Tax Department Searches Muthoot Finance Office on Oct. 29-30
Muthoot Finance says the tax department conducted a search and seizure at its registered office on Oct. 29-30, 2026.
M impact | REGULATION | Nov 02, 2026, 03:30 PM UTC
Indofood Agri Unit Cooperates With Singapore Authorities in Haze Probe
Indofood says its agriculture unit is cooperating with Singapore authorities in a haze probe.
L impact | REGULATION | Nov 02, 2026, 03:25 PM UTC
China Central Bank Intervenes Again to Stem Stock Market Declines
China's central bank intervened again on Monday to stem declines in the country's stock market. The iShares MSCI China A ETF, which tracks domestically listed companies, is down 14
M impact | REGULATION | Nov 02, 2026, 03:07 PM UTC
Lupin Wins FDA Approval for Amifampridine Tablets
The FDA approved Lupin’s 10 mg amifampridine tablets, bioequivalent to Firdapse. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivit
M impact | REGULATION | Nov 02, 2026, 02:47 PM UTC
Belgian Government in Crisis After Budget Talks Collapse
Belgium’s prime minister offers resignation after budget talks collapse.
M impact | REGULATION | Nov 02, 2026, 02:45 PM UTC
Inovio shares surge 186% after FDA approves rare-disease treatment
Inovio Pharmaceuticals shares surged 186% after the FDA approved a treatment for a rare respiratory condition.
H impact | REGULATION | Nov 02, 2026, 02:45 PM UTC